We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00401232
Recruitment Status : Completed
First Posted : November 20, 2006
Last Update Posted : February 16, 2018
Sponsor:
Information provided by (Responsible Party):
Pfizer

Brief Summary:
This is a study to collect blood from volunteers to assist in assay development.

Condition or disease Intervention/treatment
Healthy Subjects Procedure: Blood Collection

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 668 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Primary Purpose: Diagnostic
Official Title: Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
Actual Study Start Date : August 2006
Primary Completion Date : December 2017
Study Completion Date : December 2017

Arm Intervention/treatment
Arm 1 Procedure: Blood Collection
Blood Collection



Primary Outcome Measures :
  1. "No outcome measures". Blood collected for assay development. [ Time Frame: 1 hour ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy Volunteers aged 18-64

Exclusion Criteria:

  • Bleeding disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00401232


Locations
United States, Maryland
SNBL Clinical Pharmacology Center
Baltimore, Maryland, United States, 21201
United States, New Jersey
Frontage Clinical Services Inc
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer

Additional Information:
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT00401232     History of Changes
Other Study ID Numbers: 6108A1-800
B1971032 ( Other Identifier: Alias Study Number )
First Posted: November 20, 2006    Key Record Dates
Last Update Posted: February 16, 2018
Last Verified: February 2018